Artal Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $214K | Sell |
|
|||||
|
2023
Q3 | $35.8M | Hold |
|
|||||
|
2023
Q2 | $52.1M | Sell |
|
|||||
|
2023
Q1 | $46.7M | Buy |
|
|||||
|
2022
Q4 | $59.9M | Sell |
|
|||||
|
2022
Q3 | $56.5M | Buy |
|
|||||
|
2022
Q2 | $39.7M | Hold |
|
|||||
|
2022
Q1 | $52.5M | Hold |
|
|||||
|
2021
Q4 | $48.6M | Sell |
|
|||||
|
2021
Q3 | $53.1M | Sell |
|
|||||
|
2021
Q2 | $51.2M | Sell |
|
|||||
|
2021
Q1 | $34.3M | Buy |
|
|||||
|
2020
Q4 | $37.8M | Buy |
|